Northern Trust
PCVX icon

Northern Trust’s Vaxcyte PCVX Stock Holding History

Northern Trust’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.4M Buy
1,280,172
+135,703
+12% +$7.37M 0.01% 960
2026
Q1 		$66.5M Buy
1,144,469
+110,289
+11% +$5.99M 0.01% 941
2025
Q4 		$47.7M Sell
1,034,180
-39,166
-4% -$1.75M 0.01% 1137
2025
Q3 		$38.7M Sell
1,073,346
-48,546
-4% -$1.61M ﹤0.01% 1293
2025
Q2 		$36.5M Sell
1,121,892
-1,064
-0.1% -$34.9K 0.01% 1288
2025
Q1 		$42.4M Sell
1,122,956
-37,045
-3% -$2.96M 0.01% 1182
2024
Q4 		$95M Buy
1,160,001
+123,584
+12% +$12.3M 0.01% 743
2024
Q3 		$118M Buy
1,036,417
+96,691
+10% +$8.71M 0.02% 592
2024
Q2 		$71M Sell
939,726
-29,031
-3% -$1.98M 0.01% 790
2024
Q1 		$66.2M Buy
968,757
+84,489
+10% +$5.85M 0.01% 822
2023
Q4 		$55.5M Sell
884,268
-12,367
-1% -$642K 0.01% 935
2023
Q3 		$45.7M Buy
896,635
+35,694
+4% +$1.76M 0.01% 1009
2023
Q2 		$43M Buy
860,941
+192,639
+29% +$9.13M 0.01% 1061
2023
Q1 		$25M Buy
668,302
+8,971
+1% +$381K 0.01% 1405
2022
Q4 		$31.6M Buy
659,331
+175,439
+36% +$6.88M 0.01% 1225
2022
Q3 		$11.6M Buy
483,892
+19,555
+4% +$496K ﹤0.01% 1879
2022
Q2 		$10.1M Buy
464,337
+82,212
+22% +$1.9M ﹤0.01% 2026
2022
Q1 		$9.23M Buy
382,125
+10,663
+3% +$233K ﹤0.01% 2196
2021
Q4 		$8.84M Sell
371,462
-3,645
-1% -$84.8K ﹤0.01% 2320
2021
Q3 		$9.52M Buy
375,107
+9,455
+3% +$229K ﹤0.01% 2310
2021
Q2 		$8.23M Buy
365,652
+74,694
+26% +$1.53M ﹤0.01% 2504
2021
Q1 		$5.75M Buy
290,958
+67,838
+30% +$1.71M ﹤0.01% 2668
2020
Q4 		$5.93M Buy
223,120
+8,593
+4% +$319K ﹤0.01% 2576
2020
Q3 		$10.6M Buy
+214,527
New +$8.54M ﹤0.01% 2082

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Northern Trust's PCVX Position: Q2 2026 in Review

Northern Trust increased its Vaxcyte (PCVX) stake by 12% in Q2 2026, buying an estimated $7.37M and bringing the position to 1,280,172 shares worth $74.4M. The position accounts for 0.01% of the portfolio, ranked #960.

Northern Trust first reported a position in PCVX in Q3 2020 and has held it in 24 quarters since. The position peaked at $118M in Q3 2024. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Northern Trust held 1,280,172 shares of Vaxcyte worth $74.4M as of Q2 2026.
  • Northern Trust bought 135,703 Vaxcyte shares in Q2 2026, an estimated $7.37M.
  • Vaxcyte made up 0.01% of Northern Trust's portfolio in Q2 2026, its #960 holding.
  • Northern Trust first reported a position in Vaxcyte in Q3 2020 and has held it in 24 quarters since.
  • Northern Trust's Vaxcyte position peaked at $118M in Q3 2024.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.